Back to News
investment

Why Redwire Stock Rocketed 24% Higher in August

newsfeedback@fool.com (Eric Volkman)
Loading...
4 min read
0 likes
⚡ Quantum Brief
Redwire’s stock surged 24% in August 2026 after reporting record second-quarter revenue of $117 million, a near 90% year-over-year increase, and a project backlog exceeding $542 million. The company also narrowed its GAAP net loss to $41 million from $97 million in the prior-year quarter. Analysts had anticipated lower revenue and a steeper adjusted loss, but Redwire outperformed on both fronts. New contracts, including drone supply deals with a NATO country and Taiwan, alongside on-orbit drug development work, drove growth. A collaboration with SpaceX for payload resale further bolstered its pipeline.
Why it matters

The capital market’s enthusiastic response signals confidence in Redwire’s revenue trajectory and contract momentum, reinforcing its position as a high-growth player in the space and defense sectors despite ongoing profitability challenges.

AI Audio Summary
0:00 / 0:00
Click to play
99d6e805-9ff2-439c-ba4f-1232238f23dd.jpeg
Quantum News · Media Library

Redwire (RDW +0.68%) stock was hardly in the red in the last full month of 2026's summer. In fact, it posted a solid, double-digit gain of 24% across August, helped in no small part by second-quarter earnings that easily topped analyst expectations. The company also continued to secure new contracts, including one with a very prominent name in the space industry. Soaring sales Redwire published its earnings release near the start of the month, setting the tone for the remainder of August. Image source: Getty Images. The company's revenue zoomed almost 90% higher year over year to slightly over $117 million. Not surprisingly, given that kind of improvement, that figure set a new Redwire record. Also notching an all-time high was its project backlog, which was 32% higher than the end-2025 level, at over $542 million. None of this made the still-relatively young company profitable, however. Its net loss under generally accepted accounting principles (GAAP) came in at nearly $41 million, which, on the bright side, was significantly narrower than the nearly $97 million deficit in the same quarter of last year. On a non-GAAP (adjusted), per-share basis, the loss slimmed to $0.09 from $0.31. Both headline results convincingly topped the consensus analyst estimates. On average, the pundits tracking Redwire stock were estimating total revenue just shy of $108 million. They believed the company would post a much steeper adjusted net loss of $0.16 per share. Much of the year-over-year improvements in the fundamentals came from increases in good, old-fashioned project work. The quarter saw the company sign contracts to supply its Penguin drones to clients such as an unnamed North Atlantic Treaty Organization (NATO) country and the Asian island nation of Taiwan, and complete on-orbit operations for drug development activities for prominent pharmaceutical and biotech companies, among other projects. ExpandNYSE: RDWRedwirePremium FeatureMoneyball Superscore56/100Today's Change(0.68%) $0.07Current Price$10.33Key Data PointsMarket Cap$2.6BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.Day's Range$10.14 - $10.4852wk Range$4.87 - $26.64Volume10.3MAvg Vol23.9MGross Margin20.10% Double-digit growth to continue? With those tailwinds at its back, Redwire was confident enough to maintain its full-year revenue guidance of $450 million to $500 million. This would mean at least 34% growth over the 2025 result. Looking at the company's announcements in its current (third) quarter alone, this seems eminently achievable. For example, just after earnings, it revealed that its Space Microgravity Development (SpaceMD) unit had signed a collaboration agreement with Space Exploration Technologies, or SpaceX.

The Elon Musk-led company sold its payload space on a mission of Starfall, the large payload capsule it's currently developing. SpaceMD will then resell the space to drug discovery clients. The future for this company is exciting, although I'll feel much more confident when and if it consistently posts net profits. I'd say it is a speculative stock at the moment, suitable for investors with a healthy appetite for risk, that has considerable upside potential.Read NextSep 1, 2026 •By Leo Sun$1,000 Invested in Redwire Stock at Its 2026 Low Would Be Worth This Much TodayAug 24, 2026 •By Keith Noonan7 Best Satellite Stocks for 2026 and How to InvestAug 20, 2026 •By Rich SmithShould You Buy Redwire Stock Below $13?Aug 16, 2026 •By Rick OrfordBetter Space Stock: Redwire or Kratos Defense?Aug 13, 2026 •By Motley Fool TranscribingRedwire (RDW) Q2 2026 Earnings Call TranscriptAug 11, 2026 •By Rick OrfordIs Redwire Stock a Buy After Its Bold Defense Pivot?About the AuthorEric Volkman is a contributing Motley Fool finance and stock market analyst. Previously, Eric was an equities analyst at European investment bank Raiffeisen Capital and Investment. He’s also been a freelance finance writer since 1995. He studied at Susquehanna University.TMFVolkmanStocks MentionedRedwireNYSE: RDW$10.33(+0.68%)+$0.07Motley Fool Stock Advisor’s Latest PickGet Access---% Avg ReturnSpace Exploration TechnologiesNASDAQ: SPCX$140.71(-1.07%)-$1.52*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Read Original

Tags

drug-discovery
quantum-investment

Source Information

Source: The Motley Fool

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.